… COVID-19 vaccines and antibody therapies 4 . This concern is … antibodies against all known
epitope clusters on the spike protein, we noted that the activity of 17 out of the 19 antibodies …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in … glycoprotein that could lead
to antibody evasion. We 2 and … Polyclonal sera from patients infected by wild-type SARS-CoV…

… SARS-CoV-2 pandemic relies upon pan-global vaccination. Current vaccines elicit neutralizing
antibody responses to the virus … acquired or vaccine-induced antibody responses than B.…

… disappear over time, data suggest that robust memory B-cells are likely to provide a quick
source of protective antibody in the case of potential SARS-CoV-2 re-infection. In addition, in …

… of SARS-CoV-2 Omicron are now rapidly expanding, possibly due to altered antibody evasion
… Monoclonal antibodies capable of neutralizing the original Omicron variant were largely …

… SARS-CoV-2 continues to evolve, successively yielding subvariants that are not only more
transmissible but also more evasive to antibodies… by SARS-CoV-2 neutralizing antibodies. d,e…

… the SARS-CoV spike protein to isolate a neutralizing antibody … N-linked glycan acquisition
by the SARS-CoV-2 RBD confers … -reactive antibody and at least one other antibody that binds …

… Given the importance of understanding the evolution of resistance to mAbs by SARS-CoV-2, …
Unfortunately, evasion of mAb-induced protection is being reported with new SARS-CoV-2 …

… capacity of the SARS-CoV-2 antibody response in individuals and their responses to
globally emerging SARS-CoV-2 variants. Using 2 longitudinal SARS-CoV-2 community- and …

… enhanced immune evasion from current antibodies and vaccines. … Its significant evasion
from current medical treatment and … , immune evasion, and impacts of the SARS-CoV-2 variants …